Adherence to hydroxyurea therapy in children with sickle cell anemia
about
Evidence review of hydroxyurea for the prevention of sickle cell complications in low-income countriesA biopsychosocial model for the management of patients with sickle-cell disease transitioning to adult medical careA pilot study of electronic directly observed therapy to improve hydroxyurea adherence in pediatric patients with sickle-cell disease.Technology Access and Smartphone App Preferences for Medication Adherence in Adolescents and Young Adults With Sickle Cell Disease.Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults.Hydroxyurea in children with sickle cell disease: practice patterns and barriers to utilization.National trends in hospitalizations for sickle cell disease in the United States following the FDA approval of hydroxyurea, 1998-2008.Do difficulties in swallowing medication impede the use of hydroxyurea in children?Treatment for sickle cell disease in Africa: should we invest in haematopoietic stem cell transplantation?Medication adherence among pediatric patients with sickle cell disease: a systematic review.Feasibility of web-based technology to assess adherence to clinic appointments in youth with sickle cell disease.Integrating interactive web-based technology to assess adherence and clinical outcomes in pediatric sickle cell disease.Effect of communication style and physician-family relationships on satisfaction with pediatric chronic disease careRationale and design of mDOT-HuA study: a randomized trial to assess the effect of mobile-directly observed therapy on adherence to hydroxyurea in adults with sickle cell anemia in Tanzania.Hydroxyurea down-regulates BCL11A, KLF-1 and MYB through miRNA-mediated actions to induce γ-globin expression: implications for new therapeutic approaches of sickle cell diseaseHydroxyurea Therapy for Children With Sickle Cell Anemia in Sub-Saharan Africa: Rationale and Design of the REACH Trial.A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell diseasePreventive Care Delivery to Young Children With Sickle Cell Disease.A validated measure of adherence to antibiotic prophylaxis in children with sickle cell disease.Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities.Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease.Study protocol for a randomized controlled trial to assess the feasibility of an open label intervention to improve hydroxyurea adherence in youth with sickle cell disease.ENHANCE-(Electronic Hydroxyurea Adherence): A Protocol to Increase Hydroxyurea Adherence in Patients with Sickle Cell Disease.Systematic and Meta-Analytic Review: Medication Adherence Among Pediatric Patients With Sickle Cell Disease.Common gynecological challenges in adolescents with sickle cell disease.Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease.Adherence to prompt fever evaluation in children with sickle cell disease and the health belief model.Improved hydroxyurea effect with the use of text messaging in children with sickle cell anemia.A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease.Decreased fetal hemoglobin over time among youth with sickle cell disease on hydroxyurea is associated with higher urgent hospital use.Adherence to hydroxyurea medication by children with sickle cell disease (SCD) using an electronic device: a feasibility study.Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial).Development of quality indicators for transition from pediatric to adult care in sickle cell disease: A modified Delphi survey of adult providers.Prevalence of daily medication adherence among children with sickle cell disease: a 1-year retrospective cohort analysis.Family Engagement in Pediatric Sickle Cell Disease Visits.Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease.Barriers to hydroxyurea adherence and health-related quality of life in adolescents and young adults with sickle cell disease.Randomized feasibility trial to improve hydroxyurea adherence in youth ages 10-18 years through community health workers: The HABIT study.NHLBI state of the science symposium in therapeutic apheresis: Knowledge gaps and research opportunities in the area of hematology-oncology.Hydroxycarbamide adherence and cumulative dose associated with hospital readmission in sickle cell disease: a 6-year population-based cohort study.
P2860
Q24604028-88E21373-FD12-4C4E-8AA8-C910D703A0F0Q27024148-E343F1C9-B5D2-4726-B667-1ACA6228CAA3Q33440495-5E8CEBF3-EE96-451F-8832-61507E2DA98FQ33447034-E3378D57-CFBB-489B-B660-1545F69742E2Q33876417-9D6BE011-E3DD-4606-A057-95C8C958F0A4Q34026647-9FB6E606-95DE-4871-94D5-C6DE72D7DB4CQ34253814-BBFD4E1F-16CA-485E-9BB9-3FA58F150F81Q34285113-34E47C00-0F50-45CF-BFFB-9F8A5C02AC0DQ34431739-E462D396-23D6-4D8F-9C1F-2267D0DC1FC2Q34567690-19336FF8-1CE2-47ED-A766-4516FE57C218Q35851069-C35A9881-DFD3-43C7-A79E-1506D2A02057Q36023769-97EEA8A7-9447-4C4D-BCE6-17FA3197C4D7Q36145786-FABAE0C9-66F9-48A5-B6DE-40597B4C1F8FQ36166540-C9A3F559-4872-4CBD-A45D-EDCD3C368280Q36777717-8CE67753-D40A-45FC-B024-2B13687068DCQ36778962-A6C36217-D8EC-4300-81E5-DF90875336C9Q36792555-DF7C9615-95F3-49A9-83BE-1B1BB7ABBB2BQ36828467-FEC93D57-5C57-4720-8089-925712FC9A8EQ37007278-BEF56054-573E-4102-A0EE-ED8A1BF3E615Q37223344-7FB1EAE9-ABEE-48E0-846B-D24B0926ED30Q37244000-28A37608-8E44-4A15-9D80-68EDE0931221Q37258852-6F66D36B-E3B9-4F15-849B-3F858749DB1DQ37345065-108D3F76-FFE9-49FC-AA61-E006556C05FBQ38589127-5A1885C5-F20E-4279-BEB8-A4650BA9BB88Q38650270-63F16099-102F-46B0-9D80-90F6C6AF5751Q38789568-6B6A981C-A34A-4553-97CD-C9C7489D94C9Q38984325-C8A0DE08-C972-4DE2-8922-9E78D957B485Q39143787-DD8439CB-970F-41F5-B838-4712FFD61679Q39390596-724DFDD7-20B1-43DF-802D-33905CC0DD64Q39442230-8DF94F63-4F39-4214-92B7-2DD216FA2D6FQ39736284-0047D4F9-3465-4BCB-9662-933C4068720DQ40229173-F3B6BF1C-B6A9-4285-A47A-9824592051ABQ40447161-74153D53-4B3A-4195-AFE2-5C45E00B645DQ41087808-708DFC5F-E60E-490A-8D63-312814EC989BQ41337193-69002531-FD6B-4051-9C87-25B5C59D43F1Q41983509-BBD1A594-C241-41E5-83B3-6A234627D79AQ46784552-5F1E99FD-E826-4B42-9087-53D0E510F528Q48232192-45830892-A8A9-4EC5-A3FD-CC8A69081CC6Q48491917-6E7CA0CE-1321-4F73-93E1-C230800B693EQ54735877-CD8D411A-9AD7-4ACD-8006-6ECC61F26C2E
P2860
Adherence to hydroxyurea therapy in children with sickle cell anemia
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Adherence to hydroxyurea therapy in children with sickle cell anemia
@en
Adherence to hydroxyurea therapy in children with sickle cell anemia.
@nl
type
label
Adherence to hydroxyurea therapy in children with sickle cell anemia
@en
Adherence to hydroxyurea therapy in children with sickle cell anemia.
@nl
prefLabel
Adherence to hydroxyurea therapy in children with sickle cell anemia
@en
Adherence to hydroxyurea therapy in children with sickle cell anemia.
@nl
P2093
P2860
P1476
Adherence to hydroxyurea therapy in children with sickle cell anemia
@en
P2093
Agustin Calatroni
Alex R Kemper
Courtney D Thornburg
P2860
P304
P356
10.1016/J.JPEDS.2009.09.044
P407
P577
2009-11-01T00:00:00Z